ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1192

Celiac Disease in Patients with Systemic Lupus Erythematosus: An Analysis of Nationwide Inpatient Sample

Jiayi Zheng1, Ruoning Ni2, Guangchen Zou3, Yuhao Zeng4, Naeem ijaz1 and Yani Zhang5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Ascension Saint Agnes Hospital, Iowa City, IA, 3Danbury Hospital, Danbury, CT, 4Cleveland Clinic Akron General, Akron, OH, 5MedStar Union Memorial Hospital, Baltimore, MD

Meeting: ACR Convergence 2022

Keywords: Epidemiology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Epidemiology and Public Health Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Celiac disease is an autoimmune disease characterized by the immunologic reaction to gluten by lymphocytes. Although recent studies suggest an association between celiac disease and other autoimmune diseases, its relationship with systemic lupus erythematosus (SLE) remains to be elucidated. In this study, we aimed to determine the prevalence of celiac disease in patients with SLE using a US-based national database.

Methods: This is a cross-sectional study using Nationwide Inpatient Sample (NIS) from 2016 to 2018. We included hospitalizations of patients aged 18 or older, and with complete demographic information of gender, age, and race. Primary or secondary diagnoses of SLE and celiac disease were identified using International Classification of Diseases 10th edition (ICD-10). The prevalence odds ratio (OR) of celiac disease in SLE patients was assessed. Covariates for multivariate regression analysis were age, gender, race, calendar year, primary payer, household income, and comorbidities including diabetes mellitus, inflammatory bowel disease, chronic kidney disease, and metastatic malignancy. Utilization of healthcare resources including length of hospital stay and total hospitalization charges in patients with celiac disease were also examined. Categorical variables were analyzed using Chi-square test, and continuous variables using Student t-test or Wilcoxon rank-sum test. p < 0.05 was considered statistically significant. All the statistical analyses were performed using R (version 4.1.2).

Results: 372 records of patients with concurrent SLE and celiac disease were identified. The weight-adjusted inpatient prevalence of celiac disease in SLE was 0.36%, compared with 0.13% in patients without SLE. The adjusted OR of celiac disease in patients with SLE was 2.88 (95% CI: 2.60 – 3.31). The prevalence of celiac disease was higher in Caucasians, female patients, and those aged between 41 to 75. Among patients with celiac disease, patients with SLE were younger (53.3 vs 56.9%, p < 0.001), and more likely to be female (92.5% vs 71.4%, p < 0.001), and they were also associated with higher total hospitalization charges ($36299.5 vs $30281, p < 0.001) and slightly longer hospital stays (p = 0.003).

Conclusion: Patients with SLE had a higher prevalence of celiac disease than those without SLE. Among patients with celiac disease, those with SLE were associated with higher hospitalization charges and longer hospital stays.

Supporting image 1

Supporting image 2


Disclosures: J. Zheng, None; R. Ni, None; G. Zou, None; Y. Zeng, None; N. ijaz, None; Y. Zhang, None.

To cite this abstract in AMA style:

Zheng J, Ni R, Zou G, Zeng Y, ijaz N, Zhang Y. Celiac Disease in Patients with Systemic Lupus Erythematosus: An Analysis of Nationwide Inpatient Sample [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/celiac-disease-in-patients-with-systemic-lupus-erythematosus-an-analysis-of-nationwide-inpatient-sample/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/celiac-disease-in-patients-with-systemic-lupus-erythematosus-an-analysis-of-nationwide-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology